MRNA Faces AdCom On Dec.17, NVAX To Begin Phase 3 COVID Vaccine Trials In US, Mexico, AMGN On Watch

Today's Daily Dose brings you news about the progress in the COMMUNITY trial being conducted by members of the COVID R&D Alliance, vaccine efficacy of Moderna's COVID-19 vaccine as revealed in the primary analysis of its phase III trial, update regarding Novavax' phase III trial of its COVID-19 vaccine candidate NVX-CoV2373 in the U.S. and Mexico, and reverse merger of Viracta with Sunesis.

from RTT - Top Story https://ift.tt/39vTNYc
via IFTTT